Arcoma ABOSTO:ARCOMA -5.23%75 Interest Coverage is 38.96 as of Mar. 2026, which is 147% above its 10-year median of 15.76. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.85 (Fairly Valued). The stock has 4 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Arcoma AB ranks better than 63.73% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Arcoma AB's
Operating Income
for the
three
months ended in Mar. 2026 was kr0.9 Mil. Arcoma AB's Interest Expense for the
three
months ended in Mar. 2026 was kr-0.0 Mil.
Arcoma AB's interest coverage for the quarter that ended in Mar. 2026 was 38.96.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Arcoma AB's Interest Coverage or its related term are showing as below:
OSTO:ARCOMA'
s Interest Coverage Range Over the Past 10 Years
Min: 3.35 Med: 15.76 Max: 52.85
Current: 40.94
OSTO:ARCOMA's Interest Coverage is ranked better than 63.73% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs OSTO:ARCOMA: 40.94
Arcoma AB (OSTO:ARCOMA) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Arcoma AB Interest Coverage Related Terms
Arcoma AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Arcoma AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
OSTO:ARCOMA vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Arcoma AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcoma AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Arcoma AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcoma AB (OSTO:ARCOMA) has a Interest Coverage of 38.96 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Arcoma AB and its competitors. This is 147% above median its historical median of 15.76. Over the past decade, Arcoma AB's Interest Coverage has ranged from 3.35 to 52.85. According to the industry distribution chart, Arcoma AB ranks #169 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 36.3%.
Is Arcoma AB's Interest Coverage too high?
Arcoma AB's current Interest Coverage of 38.96 is 147% above median its 10-year median of 15.76. Over the past 10 years, this metric has ranged from a low of 3.35 to a high of 52.85. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Arcoma AB's value of 38.96 is 145.4% above this industry median. Based on the distribution chart, Arcoma AB ranks #169 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Arcoma AB ranks #169 out of 466 companies for Interest Coverage. This puts Arcoma AB in the upper half of its industry. The industry median Interest Coverage is 15.88. Arcoma AB's value of 38.96 is 145.4% above this benchmark. Historically, Arcoma AB's own Interest Coverage has ranged from 3.35 to 52.85 over the past decade. While the company's 10-year median is 15.76 vs. the industry median of 15.88, Arcoma AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcoma AB's current Interest Coverage of 38.96 is 145.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Arcoma AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcoma AB's current Interest Coverage is 38.96, which is 147% above median its own 10-year median of 15.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.85, compared to a current price of kr8.34 — trading 6.2% above its estimated fair value. The current Interest Coverage is 38.96, which is 147% above median its 10-year median of 15.76 and 145.4% above the Medical Devices & Instruments industry median of 15.88. Arcoma AB's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Interest Coverage is 38.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued.
The current stock price of kr8.34 is trading 6.2% above its estimated GF Value™ of kr7.85.
GuruFocus considers Arcoma AB to be Fairly Valued.
Key valuation signals for OSTO:ARCOMA:
Interest Coverage: 38.96 (147% above median its 10-year median of 15.76)
GF Value™: kr7.85 vs. price of kr8.34 (6.2% above fair value)
Industry Position: 145.4% above the Medical Devices & Instruments median (#169 of 466)
No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score
Get the complete analysis for OSTO:ARCOMA
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ARCOMA has been successfully added to your 
